1. Home
  2. SGHT vs DOMO Comparison

SGHT vs DOMO Comparison

Compare SGHT & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.52

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$2.91

Market Cap

189.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
DOMO
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
187.4M
189.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SGHT
DOMO
Price
$3.52
$2.91
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$9.08
$11.15
AVG Volume (30 Days)
368.5K
1.7M
Earning Date
05-07-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
$317,044,000.00
Revenue This Year
$11.81
$3.38
Revenue Next Year
$10.62
$4.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$2.84
52 Week High
$9.24
$18.49

Technical Indicators

Market Signals
Indicator
SGHT
DOMO
Relative Strength Index (RSI) 35.25 32.97
Support Level $3.29 N/A
Resistance Level $3.76 $5.39
Average True Range (ATR) 0.22 0.31
MACD 0.06 -0.04
Stochastic Oscillator 11.43 9.85

Price Performance

Historical Comparison
SGHT
DOMO

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: